News

Study Examines Prevalence of SARS-CoV-2 Antibodies Across U.S.

Physician's First Watch - 32 min 50 sec ago
In most regions of the U.S., less than 10% of the population had evidence of previous SARS-CoV-2 infection as of late September, according...
Categories: News

Your NEJM Group Today: Cutaneous Manifestations of Systemic Diseases / Experimental Compound for TBI / Neurology & Nephrology Opportunities

Physician's First Watch - 32 min 50 sec ago
See what's happening around NEJM Group: NEJM Group: COVID-19 Comorbidities and Cutaneous Manifestations of Systemic Diseases in Adults and Children: Join the final session...
Categories: News

Residency Training: "They Don't Make 'Em Like They Used To"

Physician's First Watch - 32 min 50 sec ago
Today's training model for new physicians is kinder, writes Dr. Vivek Sant. Not surprisingly then, older generations seem to think subsequent generations have lost a...
Categories: News

Paul Sax: Some ID Things to Be Grateful for This Holiday Season — 2020 (!) Edition

Physician's First Watch - 32 min 50 sec ago
Infectious disease specialist Dr. Paul Sax writes, "Even in the cursed year that began shortly after the first report of the disease now known as...
Categories: News

The Week in COVID-19 News

Physician's First Watch - 32 min 50 sec ago
This week, a third vaccine showed high efficacy against SARS-CoV-2, reaching 90% with one particular dosing strategy. Elsewhere, the FDA issued emergency use...
Categories: News

FDA Approves Post-Exposure Prophylaxis for Flu

Physician's First Watch - 32 min 50 sec ago
Baloxavir marboxil (marketed as Xofluza) is now approved as post-exposure prophylaxis for influenza in those aged 12 years and up. Previously, the drug was approved...
Categories: News

His ECG Showed a Heart Attack — He Just Swallowed a Battery

Physician's First Watch - 32 min 50 sec ago
Ingestion of a single AA battery led to electrocardiographic (ECG) findings consistent with acute ST-segment-elevation myocardial infarction in a 26-year-old prison...
Categories: News

Your NEJM Group Today: Dark Urine & Weakness Case / COVID-19 & Birth Outcomes / Hospitalist & Cardiologist Opportunities

Physician's First Watch - 32 min 50 sec ago
Take a look at today's highlights from NEJM Group: NEJM Primary Care/Hospitalist Page: Case record: A 72-year-old woman who had undergone mechanical...
Categories: News

Vigorous Physical Activity Tied to Lower Mortality Risk

Physician's First Watch - 32 min 50 sec ago
More vigorous physical activity could translate to lower mortality risk, according to an observational study in JAMA Internal Medicine. Researchers studied over 400,000 U.S. adults...
Categories: News

COVID-19: Another Vaccine Up to 90% Effective / Vaccine Allocation

Physician's First Watch - 32 min 50 sec ago
Here are some of the latest developments in COVID-19: Oxford/AstraZeneca vaccine: The AZD1222 adenovirus vaccine from the University of Oxford and AstraZeneca showed...
Categories: News

ECDC and WHO call for improved HIV testing in Europe

EurekAlert! - Medicine and Health - Wed, 2020-11-25 21:00
(European Centre for Disease Prevention and Control (ECDC) ) The number of people living with undiagnosed HIV is increasing in the WHO European Region. According to data published today by ECDC and the WHO/Europe, more than 136 000 people were newly diagnosed in 2019 - roughly 20% of these diagnoses were in the EU/EAA and 80% in the eastern part of the European Region. Every second HIV diagnosis (53%) happens at a late stage of the infection, when the immune system has already started to fail.
Categories: News

Big data powers design of 'smart' cell therapies for cancer

EurekAlert! - Medicine and Health - Wed, 2020-11-25 21:00
(University of California - San Francisco) Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research. In two new papers, scientists at UC San Francisco and Princeton University present complementary strategies to crack this problem with 'smart' cell therapies -- living medicines that remain inert unless triggered by combinations of proteins that only ever appear together in cancer cells.
Categories: News

A cold-health watch and warning system for cold waves in Quebec

EurekAlert! - Medicine and Health - Wed, 2020-11-25 21:00
(Institut national de la recherche scientifique - INRS) A team from the Institut national de la recherche scientifique (INRS) and the Institut national de santé publique du Québec (INSPQ), led by Professor Fateh Chebana, has recently developed a cold-health watch and warning system for cold waves, a first in the world. Their results were published in November 2020 in the journal Science of the Total Environment.
Categories: News

Scientists develop new gene therapy for eye disease

EurekAlert! - Medicine and Health - Wed, 2020-11-25 21:00
(Trinity College Dublin) Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe. The study, which involved a collaboration with clinical teams in the Royal Victoria Eye and Ear Hospital and the Mater Hospital, also has implications for a much wider suite of neurological disorders associated with ageing.
Categories: News

German researchers compile world's largest inventory of known plant species

EurekAlert! - Medicine and Health - Wed, 2020-11-25 21:00
(German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig) Researchers at Leipzig University and the German Centre for Integrative Biodiversity Research (iDiv) have compiled the world's most comprehensive list of known plant species. It contains 1,315,562 names of vascular plants, thus extending the number by some 70,000 - equivalent to about 20%. The researchers have also succeeded in clarifying 181,000 hitherto unclear species names. The data set has now been published in Scientific Data. This marks the culmination of ten years of intensive research work.
Categories: News

New drug lures stem cells to damaged tissue, improves treatment efficacy

News-Medical.Net Pharmaceutical News - Tue, 2020-11-24 21:28
Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy--a scientific first and major advance for the field of regenerative medicine.
Categories: News

Researchers describe a simple, inexpensive way to measure drug dissolution

News-Medical.Net Pharmaceutical News - Tue, 2020-11-24 21:09
When you take a time-release drug, you count on it doing what the package says: release the drug slowly into your bloodstream to provide benefits over the specified period of time.
Categories: News

Study: 58% of adults over 50 are willing to receive COVID-19 vaccination

News-Medical.Net Pharmaceutical News - Tue, 2020-11-24 05:18
Once enough people receive effective vaccines against the novel coronavirus, experts say, the end of the pandemic may be in sight. But a new poll of older adults - one of the highest-priority groups for vaccination - suggests an uphill climb lies ahead to reach that goal.
Categories: News

Study: Aprotinin can inhibit virus replication by preventing SARS-CoV2 entry into host cells

News-Medical.Net Pharmaceutical News - Mon, 2020-11-23 21:33
The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell.
Categories: News

Z-drugs can increase risk of falls, fractures, and stroke in dementia patients

News-Medical.Net Pharmaceutical News - Mon, 2020-11-23 21:14
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia - according to research from the University of East Anglia.
Categories: News
Syndicate content